Listed

PureTech Health plc: Form 20-F for the period ended Dec 31, 2022

Filed with the SEC on Apr 28, 2023 and accepted by EDGAR at Apr 28, 2023, 07:11 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2022-01-01 to 2022-12-31$15.6mifrs-full:Revenue
Operating income12 months2022-01-01 to 2022-12-31−$197.8mifrs-full:ProfitLossFromOperatingActivities
Income tax12 months2022-01-01 to 2022-12-31−$55.7mifrs-full:IncomeTaxExpenseContinuingOperations
Net income12 months2022-01-01 to 2022-12-31−$50.4mifrs-full:ProfitLossAttributableToOwnersOfParent
Diluted EPS12 months2022-01-01 to 2022-12-31−$0.18ifrs-full:DilutedEarningsLossPerShare
Basic EPS12 months2022-01-01 to 2022-12-31−$0.18ifrs-full:BasicEarningsLossPerShare
Operating cash flow12 months2022-01-01 to 2022-12-31−$178.8mifrs-full:CashFlowsFromUsedInOperatingActivities
Capital expenditure12 months2022-01-01 to 2022-12-31$2.2mifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
Cash and equivalentsAt period end2022-12-31$149.9mifrs-full:CashAndCashEquivalents
Current assetsAt period end2022-12-31$386.2mifrs-full:CurrentAssets
Total assetsAt period end2022-12-31$702.6mifrs-full:Assets
Current liabilitiesAt period end2022-12-31$96.9mifrs-full:CurrentLiabilities
Total liabilitiesAt period end2022-12-31$155.1mifrs-full:Liabilities
Shareholders' equityAt period end2022-12-31$542.2mifrs-full:EquityAttributableToOwnersOfParent
Shares outstandingAt period end2022-12-31278,566,306 sharesdei:EntityCommonStockSharesOutstanding

Source: SEC EDGAR, the filing index for accession 0001782999-23-000004. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.